BACKGROUND: Epithelial genes have previously been associated with asthma but only explain a small fraction of heritability. In part, this might be due to epistasis, which is often not considered. OBJECTIVE: We sought to determine independent and epistatic associations between filaggrin (FLG), serine protease inhibitor Kazal-type 5 (SPINK5), and thymic stromal lymphopoietin (TSLP) gene variants and childhood asthma. METHODS: Using a candidate gene approach, we genotyped 29 variants in FLG, SPINK5, and TSLP in asthmatic, allergic, and nonallergic nonasthmatic white and black children participating in the well-phenotyped Greater Cincinnati Pediatric Clinic Repository. Associations with asthma were also assessed in 6 replication populations. RESULTS: We observed independent associations of variants in SPINK5 (P = .003) and TSLP (P = .006) with childhood asthma; a SPINK5 single nucleotide polymorphism was replicated. In subjects with 1 or more SPINK5 risk alleles, the absence of the TSLP protective minor alleles was associated with a significant increase in asthma (67% vs 53%, P = .0017). In contrast, the presence or absence of TSLP minor alleles did not affect asthma risk in subjects without the SPINK5 risk alleles. The SPINK5 and TSLP epistasis was replicated in a black population (P = .036) who did not display independent association with variants in these genes. CONCLUSIONS: Our results support epistasis between SPINK5 and TSLP, which contributes to childhood asthma. These findings emphasize the importance of using biology to inform analyses to identify genetic susceptibility to complex diseases. The results from our study have clinical relevance and support that the therapeutic effects of anti-TSLP therapy in asthmatic patients might be dependent on SPINK5 genotype.
BACKGROUND: Epithelial genes have previously been associated with asthma but only explain a small fraction of heritability. In part, this might be due to epistasis, which is often not considered. OBJECTIVE: We sought to determine independent and epistatic associations between filaggrin (FLG), serine protease inhibitor Kazal-type 5 (SPINK5), and thymic stromal lymphopoietin (TSLP) gene variants and childhood asthma. METHODS: Using a candidate gene approach, we genotyped 29 variants in FLG, SPINK5, and TSLP in asthmatic, allergic, and nonallergic nonasthmatic white and black children participating in the well-phenotyped Greater Cincinnati Pediatric Clinic Repository. Associations with asthma were also assessed in 6 replication populations. RESULTS: We observed independent associations of variants in SPINK5 (P = .003) and TSLP (P = .006) with childhood asthma; a SPINK5 single nucleotide polymorphism was replicated. In subjects with 1 or more SPINK5 risk alleles, the absence of the TSLP protective minor alleles was associated with a significant increase in asthma (67% vs 53%, P = .0017). In contrast, the presence or absence of TSLP minor alleles did not affect asthma risk in subjects without the SPINK5 risk alleles. The SPINK5 and TSLP epistasis was replicated in a black population (P = .036) who did not display independent association with variants in these genes. CONCLUSIONS: Our results support epistasis between SPINK5 and TSLP, which contributes to childhood asthma. These findings emphasize the importance of using biology to inform analyses to identify genetic susceptibility to complex diseases. The results from our study have clinical relevance and support that the therapeutic effects of anti-TSLP therapy in asthmatic patients might be dependent on SPINK5 genotype.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Tolly G Epstein; Grace K LeMasters; David I Bernstein; Mark B Ericksen; Lisa J Martin; Patrick H Ryan; Jocelyn M Biagini Myers; Melinda S Butsch Kovacic; Mark A Lindsey; Hua He; Tiina Reponen; Manuel S Villareal; James E Lockey; Cheryl K Bernstein; Gurjit K Khurana Hershey Journal: Ann Allergy Asthma Immunol Date: 2012-03 Impact factor: 6.347
Authors: Joanna Ponińska; Bolesław Samoliński; Aneta Tomaszewska; Filip Raciborski; Piotr Samel-Kowalik; Artur Walkiewicz; Agnieszka Lipiec; Barbara Piekarska; Jarosław Komorowski; Edyta Krzych-Fałta; Andrzej Namysłowski; Jacek Borowicz; Grażyna Kostrzewa; Sławomir Majewski; Rafał Płoski Journal: PLoS One Date: 2011-02-18 Impact factor: 3.240
Authors: Lisa J Martin; Hua He; Margaret H Collins; J Pablo Abonia; Joceyln M Biagini Myers; Michael Eby; Hanna Johansson; Leah C Kottyan; Gurjit K Khurana Hershey; Marc E Rothenberg Journal: J Allergy Clin Immunol Date: 2017-11-10 Impact factor: 10.793
Authors: Julie M Lander; Dorothy M Supp; Hua He; Lisa J Martin; Xiaoting Chen; Matthew T Weirauch; Steven T Boyce; Raphael Kopan Journal: PLoS One Date: 2017-09-27 Impact factor: 3.240
Authors: Peter W Heymann; Huyen-Tran Nguyen; John W Steinke; Ronald B Turner; Judith A Woodfolk; Thomas A E Platts-Mills; Lisa Martin; Hua He; Jocelyn Biagini Myers; Mark Lindsey; Umasundari Sivaprasad; Mario Medvedovic; Naim Mahi; Holliday Carper; Deborah D Murphy; James Patrie; Gurjit K Khurana Hershey Journal: PLoS One Date: 2017-05-26 Impact factor: 3.240
Authors: Jayanta Gupta; Elisabet Johansson; Jonathan A Bernstein; Ranajit Chakraborty; Gurjit K Khurana Hershey; Marc E Rothenberg; Tesfaye B Mersha Journal: J Allergy Clin Immunol Date: 2016-06-11 Impact factor: 10.793
Authors: Elisabet Johansson; Lisa J Martin; Hua He; Xiaoting Chen; Matthew T Weirauch; John W Kroner; Gurjit K Khurana Hershey; Jocelyn M Biagini Journal: Clin Exp Allergy Date: 2021-02-13 Impact factor: 5.401